Company intelligence / Profile preview

ThinkSono

Ruislip, England, United Kingdomthinksono.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company's flagship product, ThinkSono Guidance, has achieved Class IIb CE mark and EU/UK regulatory approval. It enables non-ultrasound-trained healthcare professionals to perform DVT scans at the point of care using real-time AI guidance. Over 1,000 patients have been scanned in prospective double-blinded multi-center clinical trials across the UK and EU. US FDA clearance for commercialization in the US market remains pending.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapyAI-powered diagnostic software
Industry: Medical Imaging

Partnerships

NYU Langone Health (US)Temple Health (US)Multiple hospitals across UK, Germany and Greece

Beyond the preview

Go deeper on ThinkSono.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ThinkSono.

Explore the full profile